Surgery Partners (SGRY) Receivables (2014 - 2026)

Surgery Partners' Receivables history runs 13 years deep, the most recent figure standing at $603.4 million for Q1 2026.

• In Q1 2026, Receivables rose 5.75% year-over-year to $603.4 million; the TTM figure through Mar 2026 stood at $603.4 million (up 5.75% YoY), while the FY2025 annual figure was $602.2 million, up 3.99% from the prior year.
• Receivables came in at $603.4 million for Q1 2026 at Surgery Partners, roughly flat from $602.2 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $603.4 million in Q1 2026 to a low of $412.0 million in Q2 2022.
• A 5-year average of $507.3 million and a median of $496.4 million in 2023 frame the typical range for Receivables.
• Across the five-year window, Receivables grew 17.31% in 2024 and gained 3.99% in 2025, its largest moves.
• Surgery Partners' Receivables stood at $456.3 million in 2022, then rose by 8.79% to $496.4 million in 2023, then rose by 16.66% to $579.1 million in 2024, then increased by 3.99% to $602.2 million in 2025, then rose by 0.2% to $603.4 million in 2026.
• According to Business Quant data, Receivables over the past three periods registered $603.4 million, $602.2 million, and $579.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison